Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Edward Muller, M.D.

Co-Author

This page shows the publications co-authored by James Muller and Ahmed Tawakol.
Connection Strength

0.769
  1. Through the looking glass: an angioscopic view of the effect of statin therapy on coronary artery plaques. J Am Coll Cardiol. 2003 Aug 20; 42(4):687-9.
    View in: PubMed
    Score: 0.274
  2. Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor. Photochem Photobiol Sci. 2008 Jan; 7(1):33-9.
    View in: PubMed
    Score: 0.092
  3. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006 Nov 07; 48(9):1818-24.
    View in: PubMed
    Score: 0.085
  4. New opportunities for identification and reduction of coronary risk: treatment of vulnerable patients, arteries, and plaques. J Am Coll Cardiol. 2006 Apr 18; 47(8 Suppl):C2-6.
    View in: PubMed
    Score: 0.082
  5. Photosensitizer delivery to vulnerable atherosclerotic plaque: comparison of macrophage-targeted conjugate versus free chlorin(e6). J Biomed Opt. 2006 Mar-Apr; 11(2):021008.
    View in: PubMed
    Score: 0.082
  6. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2005 May-Jun; 12(3):294-301.
    View in: PubMed
    Score: 0.077
  7. High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease. J Am Coll Cardiol. 2005 May 17; 45(10):1580-4.
    View in: PubMed
    Score: 0.077
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.